Results 61 to 70 of about 2,027 (134)

Modulación de la estabilidad de la quinasa de receptores acoplados a proteínas G (GRK2) por la ligasa Mdm2: implicaciones fisiológicas en la migración y la proliferación celular [PDF]

, 2007
Tesis Doctoral inédita leída en la Universidad Autónoma de Madrid, Facultad de Ciencias, Departamento de Biología Molecular.
Salcedo de Haro, Alicia
core   +1 more source

Exploratory role of protein kinase CK2 synergy in treatment of breast cancer [PDF]

, 2016
Breast cancer is the second most common type of cancer among women. The serine-threonine protein kinase CK2 is overexpressed in many cancers, including lung, prostate, hematologic cancers, and breast (Pinna, 2013).
Shah, Anil Ajit
core   +1 more source

Photodynamic Therapy As An Effective Therapeutic Approach In Mame Models Of Triple Negative And Inflammatory Breast Cancers [PDF]

, 2015
Introduction: Photodynamic therapy (PDT) is a minimally invasive, FDA approved therapy for treatment of several indications including endobronchial and esophageal cancers that are accessible to light. Triple negative breast cancer (TNBC) and inflammatory
Aggarwal, Neha
core   +1 more source

Acidic Pericellular Ph: Effects On Proteolysis And Gene Expression As Determined In 3d Models Of Breast Carcinoma [PDF]

, 2013
Among the non-cellular microenvironmental factors that contribute to malignancy of solid tumors is an acidic peritumoral pH. The first objective was to determine if an acidic extracellular pH observed in vivo (i.e., pHe 6.8) affects the activity of ...
Rothberg, Jennifer M.
core   +1 more source

EZH2 T416 Phosphorylation Enhances Breast Cancer Tumorigenesis [PDF]

, 2013
Enhancer of zeste homologue 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2 (PRC2) and catalyzes the trimethylation of histone H3 on lysine 27 (H3K27Me3), to repress gene transcription.
LaBaff, Adam M, LaBaff, Adam M
core  

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer [PDF]

, 2015
Alexios Matikas, Dimitris Mavroudis, Eleni Politaki, Hara Polioudaki, Panayiotis A Theodoropoulos, Rena Chiotaki, Sofia Agelaki, Vassilis Georgoulias   +7 more
core   +1 more source

Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival [PDF]

, 2010
Xiao-Yang Wang, Luiz OF Penalva, Hongyan Yuan, R Ilona Linnoila, Jiachun Lu, Hideyuki Okano, Robert I Glazer   +6 more
core   +1 more source

ARHGEF6 downregulation as a key mediator of tumor cell apoptosis in breast cancer. [PDF]

Oncol Lett
Zhang Y, Zhou D, Shen X, Song Q, Yang L, Li W, Zhao X, Fang W, Liu B, Xing C, Liu J, Fang H, Zhang Q.   +12 more
europepmc   +1 more source

Identification of non-oncology drugs with activity against inflammatory and triple-negative breast cancer cell lines. [PDF]

Oncol Lett
Ahmad S, Kandil S, Williams KP, Scott JE.   +3 more
europepmc   +1 more source

Jacaric Acid Empowers RSL3-Induced Ferroptotic Cell Death in Two- and Three-Dimensional Breast Cancer Cell Models. [PDF]

Int J Mol Sci
Cuvelier G, Vermonden P, Debisschop P, Martin M, Derouane F, Liebisch G, Ecker J, Hoering M, Berlière M, Van Bockstal M, Galant C, Duhoux F, Mourao L, Scheele C, Feron O, Rezsohazy R, Corbet C, Larondelle Y.   +17 more
europepmc   +1 more source